作者: Jie Gao , Lei Tian , Guobin Weng , Nicholas V. Bhagroo , Robert L. Sorenson
DOI: 10.1111/J.1432-2277.2011.01332.X
关键词: Insulin 、 Agonist 、 Islet 、 Medicine 、 Receptor 、 Beta cell 、 Oleoylethanolamide 、 Internal medicine 、 Transplantation 、 Endocrinology 、 In vivo
摘要: G protein-coupled receptor 119 (GPR119) is predominantly expressed in β cells and intestinal L cells. In this study, we investigated whether oleoylethanolamide (OEA), a GPR119 endogenous ligand, PSN632408, synthetic agonist, can stimulate β-cell replication vitro vivo improve islet graft function diabetic mice. We found that OEA PSN632408 significantly increased numbers of insulin(+)/5-bromo-2'-deoxyuridine (BrdU)(+) cultured mouse islets dose-dependent manner. All recipient mice, given marginal syngeneic transplants with or vehicle, achieved normoglycemia at 4 weeks after transplantation. However, was faster OEA- PSN632408-treated mice than vehicle-treated (P < 0.05). The percentage insulin(+)/BrdU(+) grafts higher 0.01). Our data demonstrated function. Targeting novel therapeutic approach to increase mass by stimulating replication.